Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10
Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genzyme Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Genzyme Acquires Caprelsa from AstraZeneca 13
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million 14
Venture Financing 15
Edimer Pharma Raises US$18 Million In Series B Financing 15
Ultragenyx Pharma Raises US$75 Million In Series B Financing 17
Partnerships 19
Alnylam Pharma Enters into Agreement with Sanofi Genzyme 19
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Ablynx Enters into Research Agreement with Genzyme 22
Voyager Therapeutics Enters into Development Agreement with Genzyme 23
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 24
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 25
Genzyme Enters Into Research Agreement With Cleveland Clinic 26
Alnylam Pharma And Genzyme Enter Into Agreement For RNAi Therapeutics As Genetic Medicines 27
Alnylam Pharma And Genzyme Expands Co-Development Agreement For RNAi Therapeutics 29
Merger 30
Sanofi Japan and Genzyme Japan Merge 30
Licensing Agreements 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 32
Equity Offering 33
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 33
KaloBios Pharma Completes IPO For US$70 Million 34
Asset Transactions 36
Admedus Acquires Manufacturing Facility From Genzyme Australasia 36
Genzyme Corp – Key Competitors 37
Genzyme Corp – Key Employees 38
Genzyme Corp – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Joint Venture 41
Recent Developments 42
Clinical Trials 42
Apr 11, 2017: Sanofi Genzyme to present data on GLD52 (GZ402668) at AAN 42
Feb 14, 2017: Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease 43
Other Significant Developments 44
Mar 22, 2017: Sanofi Genzyme Extends Its Multiple Myeloma Journey Partners Program To Cities Nationwide To Help Improve Patient Outcomes Through Peer-to-Peer Education 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45
Genzyme Corp, Pharmaceuticals & Healthcare, Key Facts 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10
Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Genzyme Acquires Caprelsa from AstraZeneca 13
Genzyme Completes Acquisition Of Leukine Manufacturing Facility From Bayer HealthCare For US$98.5 Million 14
Edimer Pharma Raises US$18 Million In Series B Financing 15
Ultragenyx Pharma Raises US$75 Million In Series B Financing 17
Alnylam Pharma Enters into Agreement with Sanofi Genzyme 19
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 20
Recursion Pharma Enters into Research Agreement with Genzyme 21
Ablynx Enters into Research Agreement with Genzyme 22
Voyager Therapeutics Enters into Development Agreement with Genzyme 23
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 24
Charcot-Marie-Tooth Association Enters into Agreement with Genzyme to Discover Therapies for CMT1A 25
Genzyme Enters Into Research Agreement With Cleveland Clinic 26
Alnylam Pharma And Genzyme Enter Into Agreement For RNAi Therapeutics As Genetic Medicines 27
Alnylam Pharma And Genzyme Expands Co-Development Agreement For RNAi Therapeutics 29
Sanofi Japan and Genzyme Japan Merge 30
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 31
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 32
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 33
KaloBios Pharma Completes IPO For US$70 Million 34
Admedus Acquires Manufacturing Facility From Genzyme Australasia 36
Genzyme Corp, Key Competitors 37
Genzyme Corp, Key Employees 38
Genzyme Corp, Other Locations 39
Genzyme Corp, Subsidiaries 39
Genzyme Corp, Joint Venture 41
List of Figures
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Genzyme Corp, Medical Devices Deals, 2012 to YTD 2018 10